PKM2-IN-12
PKM2-IN-12 is an orally active PKM2 inhibitor with an IC50 of 10 nM. PKM2-IN-12 inhibits COLO-205 cell proliferation and migration, arrests the cell cycle, and induces apoptosis. PKM2-IN-12 significantly reduces cellular levels of lactate, pyruvate, and ROS. PKM2-IN-12 directly kills cancer cells and restores disrupted gut microbiota balance in mice model. PKM2-IN-12 can be used to study colorectal cancer[1].
Product Specifications
UNSPSC
12352005
Target
Apoptosis; Endogenous Metabolite; Pyruvate Kinase; Reactive Oxygen Species (ROS)
Related Pathways
Apoptosis; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
O=C(C1=C(C2=CC=C(Cl)C=C2)N=C(NC3=CC=C(Cl)C=C3)S1)C4=CN=C5C=CC=CN54
Molecular Formula
C23H14Cl2N4OS
Molecular Weight
465.35
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PKM2
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD106 / VCAM1 (B-K9), CF568 conjugate, 0.1mg/mL
CD63 (MX-49.129.5), CF594 conjugate, 0.1mg/mL
Blood Group Antigen B (CD173) (HEB-20), CF405S conjugate, 0.1mg/mL
CD22 / BL-CAM (B-Cell Marker) (RFB4), CF740 conjugate, 0.1mg/mL
